Industry Analysis & Industry Trends
Cutting its losses
Despite being a discretionary product, demand for hair loss treatments has remained relatively strong. Revenue for hair loss treatment manufacturers will grow steadily over the next five years, supported by a patent cliff for major products Rogaine and Propecia. While the companies that manufacture these products will likely face a decline in profit, consumers will purchase more generic hair loss treatments. Furthermore, the aging population will increase the instances of male pattern baldness, boosting demand.... purchase to read more
Industry Report - Industry Products Chapter
Oral hair loss treatments
Hair loss treatments are available in several forms, ranging from topical applications to laser hair follicle stimulators. IBISWorld estimates that the largest product segment comprises orally ingestible solutions, which account for 38.0% of industry revenue. These products include patented brand name prescription drugs like Merck's Propecia, which employs finasteride as its active ingredient. Finasteride works to treat male pattern baldness by blocking the production of a hormone in the scalp that causes the condition. It does not thicken hair and it does not work in women or children. Other ingestible products are also available, and they most commonly contain finasteride as the main component... purchase to read more